Chapter 138: Crazy Broad Institute
Broad Institute, in the director's office.

The office was filled with smoke at this time. Church, the director of the Broad Institute, who was sitting in the main seat, kept smoking, showing his bored mood.

Sitting opposite him was Zhang Feng, a super genius in the field of genetic research and development at the Broad Institute.

At this time, Zhang Feng was concentrating on looking at a pile of technical patent information in his hand, and a look of realization or joy flashed across his face from time to time.

It seems that this technical patent information is a priceless treasure to Zhang Feng.

The above patented technology treatment solved the problems he had encountered in the past, and he showed an expression of sudden enlightenment, with flashes of joy in his eyes from time to time.

Finally, after more than an hour, Zhang Feng finally put down the technical patent information in his hand, and then sighed with a complicated expression:

"There is always someone better than you."

After reading this large amount of technical patent information, Zhang Feng was pleasantly surprised, but his inner pride was also hit so hard that he became a little autistic.

Zhang Feng was born in the north of Daxia in 82. He immigrated to the United States with his parents when he was young. He showed amazing learning talent at an early age when he was in school.

He graduated from Harvard University at the age of 22 and obtained a Ph.D. in chemical and biological engineering from Stanford University at the age of 27.

While studying for a master's degree, he made a large number of scientific research contributions and achieved a lot of results, successfully promoting the new discipline of optogenetics into a popular discipline.

Then I headed straight for the study of gene editing.

In 2012, just half a year later than the Max Planck Institute, it successfully pioneered the gene editing technology for animal and plant cells.

It successfully seized the core technology patent of CRISPR/Cas9 gene editing technology, and after that, relied on the continuous research and development funds from the Broad Institute.

He has successfully created an amazing miracle in the field of gene editing, publishing several major papers every month in the two major academic journals "Nature" and "Biology".

Under such circumstances, relying on several blockbuster papers and related technical patents every month, the leadership of CRISPR/Cas9 gene editing technology has been directly usurped by the Broad Institute!

From then on, Zhang Feng was called the top three giants in the field of CRISPR/Cas9 gene editing by the global academic community!

However, just as Zhang Feng was becoming a little overwhelmed by the praise from the outside world, a kind of arrogance that he was invincible in the field of CRISPR/Cas9 gene editing technology gradually grew.

Now after reading the series of technical patent materials submitted by Church, the director of the Broad Institute, Zhang Feng just felt like a piece of trash!
I deeply felt what it means that there are always people better than you, and I felt the gap between ordinary people and super geniuses!

The pride he had accumulated in the past was completely shattered by this pile of technical patent information. The fact that he did not collapse now showed how tough he was.

“Do we have a chance to catch up with Xingtu Genetics?”

Church, the director of the Broad Institute, who was still smoking, flicked the ash and asked Zhang Feng with a serious face.

"There is hope. After reading this pile of technical patent information, my mind was suddenly opened up and I no longer have any doubts about the future."

Although the technical development route of this technical patent material is not the traditional viral transformation method, but a brand-new RNP complex route.

But they are both CRISPR/Cas9 gene editing technology lines, and they still have some similarities.

So after Zhang Feng read a series of technical patent information on the RNP complex line of Xingtu Gene Company, he also understood a lot of things and had many innovative research and development ideas.

"How long will it take to catch up with them?"

After exhaling a puff of smoke, Church asked about Zhang Feng, the worry expression on his face still as strong as ever.

“Three years, give me three years, I can catch up with the research and development progress of Xingtu Gene Company and make CRISPR/Cas9 gene editing technology truly practical!”

Zhang Feng gave his answer, but this answer made the director of the Broad Institute, Church, shake his head and show a dissatisfied expression on his face. "It's too long. I can't wait that long, and I can't accept it for that long.

After all, through the analysis of the technical patents registered by Star Path Gene Company in the past two weeks, anyone can see that their gene editing technology is already quite mature.

It can be said that their CRISPR/Cas9 gene editing technology has truly matured and is truly practical.

If it takes us three years to catch up with their current progress, it will be too late, so I and even the investors behind the Broad Institute cannot wait!"

After hearing the words of Church, director of the Broad Institute, Zhang Feng was silent for a while, and then felt helpless.

Because R&D progress is not something you can improve just by being impatient. If being impatient would be helpful, then humans would have already left the earth and developed the solar system.

“After reading these technical materials, do you have the confidence to speed up the research and development progress through a large number of human experiments while drawing on some of the other party’s technical patents?

At the very least, we have to come up with some fake achievements to build momentum and gain a head start!"

"Ok?"

Hearing what Church said, Zhang Feng frowned deeply, because this was not a good thing.

According to the information in this technical patent, Xingtu Gene Company has completely blocked the advancement of the RNP complex technology line in these two weeks.

So the only thing they could do at the Broad Institute was to bypass the RNP complex technology line.

However, considering the difficulty of developing new routes, the fastest way to achieve results is still to use the viral transformation technology they have been researching.

However, even with the technical patent information of Xingtu Gene Company, the current viral transformation technology route has suddenly improved the research and development progress by a large step by analogy.

But there is still a long way to go before it can be truly practical, which is why he said it will take three years to complete the research and development.

But now Church wants to produce results quickly, and even wants to falsify information to create momentum...

This is simply playing with human lives. This is gambling with human lives on the probability of failure and success!
After all, the biggest drawback of the viral transformation method is that there is a certain probability of off-target effects.

Moreover, it is not easy to remove the artificially edited virus implanted in the body. This is an unknown hidden danger!

Thinking of the huge risk of failure in the experiment, Zhang Feng immediately shook his head and refused:
"It's impossible to get results quickly. Even if you can succeed, it's just gambling with human lives. It's useless."

"Zhang Feng, to develop this thing you must first have money to achieve scientific research results, but if you want to have money, you must let the investors see the hope of success and a bright future.

Now that the RNP complex technology line of Xingtu Gene Company has matured and can be put into practical use, the CRISPR/Cas9 gene editing technology will surely become famous all over the world.

Among them, we are the first research institution to develop CRISPR/Cas9 gene editing technology.

We must demonstrate our own value. Only in this way can we welcome the investment boom driven by Star Path Gene Company.

So no matter what, we have to prove our own strength and potential.

Only in this way can the bulk of the investment funds driven by Star Path Genetics fall into our Broad Institute.

Eventually we will have more money to buy more scientific research equipment and hire more scientists and researchers, so as to quickly put the viral transformation technology into practical use!

Therefore, we must achieve major scientific research results in a short period of time, even if these major scientific research results are false, have great hidden dangers, and even cause accidental deaths...

But as long as there are successful cases, it will make our Broad Institute the first priority for global capital investment, Zhang Feng, do you understand?"

(End of this chapter)